| PRD_000998 | Name: | [Aba3,16]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_000999 | Name: | ALPHA-BETA-FOLDAMER 2C | Formula: | C110 H166 N28 O28 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001002 | Name: | [Aba3,7,12,16]BTD-2 | Formula: | C82 H156 N36 O18 S2 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_001006 | Name: | [Aba5,7,12,14]BTD-2 | Formula: | C82 H156 N36 O18 S2 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_001009 | Name: | [Aba3,5,7,12,14,16]BTD-2 | Formula: | C84 H162 N36 O18 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_001013 | Name: | Peptide Inhibitor (ACE)ADVAD-CHO | Formula: | C21 H33 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001014 | Name: | APO-monomer | Formula: | C115 H198 N39 O24 | Definition date: | 2013-04-17 | Last modified: | 2013-06-03 |
|
| PRD_001020 | Name: | GDC0152 | Formula: | C25 H34 N6 O3 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001030 | Name: | ACE-PHE-GLU-LYS-ALA chloromethylketone INHIBITOR | Formula: | C26 H41 Cl N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001039 | Name: | BICYCLIC PEPTIDE INHIBITOR UK504 | Formula: | C55 H94 N23 O16 S4 | Definition date: | 2013-05-15 | Last modified: | 2013-06-03 |
|
| PRD_001045 | Name: | TMC-95A mimic ligand yCP:4a chain P | Formula: | C43 H47 N5 O9 | Definition date: | 2013-05-01 | Last modified: | 2013-06-03 |
|
| PRD_001048 | Name: | N-acetyl-L-valyl-L-alpha-aspartyl-L-valyl-N-[(2R)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | Formula: | C23 H37 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001052 | Name: | N-acetyl-L-alpha-aspartyl-L-valyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | Formula: | C18 H28 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001054 | Name: | peptide inhibitor, syc59 | Formula: | C24 H38 N4 O6 | Definition date: | 2013-02-20 | Last modified: | 2013-06-03 |
|
| PRD_001057 | Name: | ACETYL-PEPSTATIN | Formula: | C31 H57 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001061 | Name: | peptide inhibitor, syc 10 | Formula: | C30 H42 N4 O6 | Definition date: | 2013-02-20 | Last modified: | 2013-06-03 |
|
| PRD_001062 | Name: | peptide inhibitor, syc8 | Formula: | C28 H38 N4 O6 | Definition date: | 2013-02-20 | Last modified: | 2013-06-03 |
|
| PRD_001076 | Name: | "N-[(benzyloxy)carbonyl]-L-valyl-N~5~-[amino(iminio)methyl]-L-ornithyl-N-[(3R)-6-{[amino(iminio)methyl]amino}-1-fluoro-2-oxohexan-3-yl]-L-prolinamide | Formula: | C31 H51 F N10 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001082 | Name: | Tripeptide fluoromethyl ketone inhibitor Z-VAE(OMe)-FMK | Formula: | C23 H32 F N3 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001088 | Name: | D-peptide inhibitor | Formula: | C75 H106 N17 O17 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001091 | Name: | monomeric peptide inhibitor | Formula: | C72 H103 N19 O16 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001092 | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-cysteinamide | Formula: | C23 H37 N8 O4 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001093 | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-isoleucinamide | Formula: | C26 H43 N8 O4 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001095 | Name: | N~2~-[(2S)-2-{[(benzyloxy)carbonyl]amino}-7-ethoxy-7-oxoheptanoyl]-L-glutaminyl-L-prolyl-L-leucine | Formula: | C33 H49 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001098 | Name: | TMC-95A mimic ligand 2b | Formula: | C42 H47 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|